CSHNX
Price
$12.51
Change
+$0.06 (+0.48%)
Updated
Jan 17 closing price
Net Assets
1.17B
SAIEX
Price
$11.11
Change
+$0.07 (+0.63%)
Updated
Jan 17 closing price
Net Assets
210.42M
Ad is loading...

CSHNX vs SAIEX

Header iconCSHNX vs SAIEX Comparison
Open Charts CSHNX vs SAIEXBanner chart's image
NYLI Cushing® MLP Premier Investor Class
Price$12.51
Change+$0.06 (+0.48%)
VolumeN/A
Net Assets1.17B
Spirit of America Energy Institutional
Price$11.11
Change+$0.07 (+0.63%)
VolumeN/A
Net Assets210.42M
CSHNX vs SAIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSHNX vs. SAIEX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSHNX is a Hold and SAIEX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CSHNX has more cash in the bank: 1.17B vs. SAIEX (210M). SAIEX pays higher dividends than CSHNX: SAIEX (16.06) vs CSHNX (7.86). CSHNX was incepted earlier than SAIEX: CSHNX (11 years) vs SAIEX (5 years). CSHNX is a more actively managed with annual turnover of: 20.00 vs. SAIEX (15.00). CSHNX has a lower initial minimum investment than SAIEX: CSHNX (2500) vs SAIEX (100000). CSHNX annual gain was more profitable for investors over the last year : 57.33 vs. SAIEX (34.34).
CSHNXSAIEXCSHNX / SAIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years5 years-
Gain YTD9.54510.00095%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets1.17B210M556%
Annual Yield % from dividends7.8616.0649%
Returns for 1 year57.3334.34167%
Returns for 3 years104.9077.32136%
Returns for 5 years85.63N/A-
Returns for 10 years34.46N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FINV7.020.04
+0.57%
FinVolution Group
GRFS7.270.03
+0.41%
Grifols SA
INUV0.45N/A
+0.25%
Inuvo
AJG294.82-0.97
-0.33%
Arthur J Gallagher & Co
TRVI3.76-0.02
-0.53%
Trevi Therapeutics